Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Biogen (NASDAQ:BIIB) shares experienced a change in market expectations as Cantor Fitzgerald revised the company's price target. The new target has been set at $206.00, a decrease from the previous ...

Brightcove's deal is one of several large acquisitions of local technology companies expected to close in 2025. Those include Markforged, which is set to be acquired by Waltham's Nano Dimension, and ...

Biogen Inc. (BIIB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...